Its chairman Seo Jung-jin said it plans to decide about the location of its third overseas factory during the first half of 2018. "We are responding swiftly to market changes. Celltrion is planning to supply diabetes copycat drugs across the world," Seo said in a recent meeting held in Italy. By contrast, critics ...